Table 1 Patient demographics and clinical characteristics within ependymoma and pilocytic astrocytoma tumor patient cohorts

Patients

88

80

 Male

48

42

 Female

40

38

 Median (Mean ± SD)

37 (35 ± 21)

9 (14 ± 14)

 Minimum

1

0

 Maximum

73

58

 Survivors in the end of the follow-up

60

69

 Follow-up time for survivors (m) (median (mean ± SD))

125 (135 ± 82)

70 (111 ± 89)

 5-year residive-free survival (%)

71

82

 5-year survival (%)

82

93

Tumors

108

80

 Primary

74

73

 Second

14

5

 Third

14

1

 Fourth-sixth

6

1

 I

18

80

 II

68

0

 III

22

0

 Supratentorial

35

3

 Infratentorial

28

69

 Spinal

43

2

 Cranial nerve

0

6